Angion Biomedica was a United States biopharmaceutical company focused on the discovery and development of small-molecule medicines for kidney and cardiorenal diseases and acute organ injury.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!